Literature DB >> 8771990

A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population.

H Nishio1, M J Lee, M Fujii, K Kario, K Kayaba, K Shimada, M Matsuo, K Sumino.   

Abstract

Hyperhomocysteinemia has been reported as an independent risk factor for atherosclerotic cerebrovascular and coronary heart diseases. 5, 10-Methylenetetrahydrofolate reductase (MTHFR) is one of the enzymes responsible for hyperhomocysteinemia. The C to T transition of the MTHFR gene at nucleotide position 677 results in decreasing the enzymatic activity and increasing the plasma homocysteine level. We studied the distribution of the MTHFR gene mutation among the Japanese population. The subjects were 129 Japanese males (aged 40-59 years). The allele frequency of the mutation was 0.38. The frequencies of the three genotypes were as follows: +/+, 11%; +/-, 54%; -/-, 35% (+ and-indicate the presence and absence of the mutation, respectively). We also studied the frequency of the MTHFR gene mutation in the middle-aged Japanese males with hypertension to investigate the possibility that this mutation is related to essential hypertension. The normotensive and hypertensive subjects were identical in the distribution of the mutated allele and the frequencies of the three genotypes. Furthermore, the prevalence of hypertension in each genotype group was same, although the mean diastolic pressure of the group with homozygous mutation was significantly higher than that of other groups (p < 0.05). Therefore, we concluded that there was no significant relationship between the MTHFR gene mutation and hypertensive subjects studied in this study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771990     DOI: 10.1007/BF01875985

Source DB:  PubMed          Journal:  Jpn J Hum Genet        ISSN: 0916-8478


  12 in total

1.  Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype.

Authors:  Koichi Miyaki; Mitsuru Murata; Haruhito Kikuchi; Izumi Takei; Takeo Nakayama; Kiyoaki Watanabe; Kazuyuki Omae
Journal:  J Hum Genet       Date:  2005-05-14       Impact factor: 3.172

2.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults.

Authors:  C F Skibola; M T Smith; E Kane; E Roman; S Rollinson; R A Cartwright; G Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 3.  Methylenetetrahydrofolate Reductase Polymorphism (rs1801133) and the Risk of Hypertension among African Populations: A Narrative Synthesis of Literature.

Authors:  Sihle E Mabhida; Babu Muhamed; Jyoti R Sharma; Teke Apalata; Sibusiso Nomatshila; Lawrence Mabasa; Mongi Benjeddou; Charity Masilela; Khanyisani Ziqubu; Samukelisiwe Shabalala; Rabia Johnson
Journal:  Genes (Basel)       Date:  2022-04-01       Impact factor: 4.141

4.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

5.  Association of methylentetraydrofolate reductase (MTHFR) 677 C > T gene polymorphism and homocysteine levels in psoriasis vulgaris patients from Malaysia: a case-control study.

Authors:  Siaw C Liew; Esha Das-Gupta; Shew F Wong; Nagarajah Lee; Najeeb Safdar; Adawiyah Jamil
Journal:  Nutr J       Date:  2012-01-05       Impact factor: 3.271

Review 6.  Genetic polymorphisms in homocysteine metabolism and response to folate intake: a comprehensive strategy to elucidate useful genetic information.

Authors:  Koichi Miyaki
Journal:  J Epidemiol       Date:  2010-06-19       Impact factor: 3.211

7.  Antiepileptic drug-induced psychosis associated with MTHFR C677T: a case report.

Authors:  Masaru Shimura; Hikari Yamada; Hidekuni Takahashi; Naoto Yamada; Soken Go; Gaku Yamanaka; Hisashi Kawashima
Journal:  J Med Case Rep       Date:  2019-08-12

Review 8.  Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.

Authors:  Shanel Raghubeer; Tandi E Matsha
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

Review 9.  Association Between MTHFR Polymorphisms and the Risk of Essential Hypertension: An Updated Meta-analysis.

Authors:  Hao Meng; Shaoyan Huang; Yali Yang; Xiaofeng He; Liping Fei; Yuping Xing
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

10.  Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China.

Authors:  Heming Wu; Qingyan Huang; Zhikang Yu; Zhixiong Zhong
Journal:  BMC Cardiovasc Disord       Date:  2022-03-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.